IP Library Granted Patent US 9,713,604
Granted Patent B2
US 9,713,604 · App. 14/258,074 · Granted Jul 25, 2017

Antioxidant compositions and methods of using the same

Inventor: Frank Dreher (San Francisco, CA)
Assignee: ANTEIS SA
A61K31/375A61K8/44A61K8/585A61K8/676A61K8/678A61K8/891A61K9/0014A61K31/197A61K31/198A61K31/353A61K31/355A61K31/695A61K47/34A61Q19/00A61Q19/004A61Q19/08A61K2800/31A61K2800/522
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,713,604
App. No.
14/258,074
Granted
Jul 25, 2017
Kind
B2
Abstract

The invention provides non-irritating, stable topical compositions including at least Vitamin C, Vitamin E and a polyphenol antioxidant. Such compositions can be used to facilitate the prevention or treatment of free oxygen, nitrogen, and/or other free radical related skin damage. Also provided are methods for modifying free radical damage to skin by administering such compositions in an amount sufficient to treat and/or prevent free radical damage to the skin.

Claims (37)

1. An antioxidant composition comprising at least one topically acceptable silicone oil in combination with an effective amount of Vitamin C, Vitamin E, and one or more polyphenol antioxidants.

2. The antioxidant composition of claim 1 , wherein the composition further comprises at least one additional antioxidant.

3. The antioxidant composition of claim 2 , wherein the at least one additional antioxidant is creatine.

4. The antioxidant composition of claim 1 , wherein the composition further comprises at least one low molecular weight chromane or chromene derivative with antioxidant properties.

5. The antioxidant composition of claim 3 , wherein the composition further comprises at least one low molecular weight chromane or chromene derivative with antioxidant properties.

6. The antioxidant composition of claim 1 , wherein Vitamin C is present in an amount between 1 and 30%.

7. The antioxidant composition of claim 1 , wherein Vitamin E is present in an amount between 0.1 and 5%.

8. The antioxidant composition of claim 3 , wherein creatine is present in an amount between 0.1 and 5%.

9. The antioxidant composition of claim 4 , wherein the at least one low molecular weight chromane or chromene derivative with antioxidant properties is dimethylmethoxy chromanol.

10. The antioxidant composition of claim 5 , wherein the at least one low molecular weight chromane or chromene derivative with antioxidant properties is dimethylmethoxy chromanol.

11. The antioxidant composition of claim 9 , wherein the dimethylmethoxy chromanol is present in an amount between 0.01 and 1%.

12. The antioxidant composition of claim 10 , wherein the dimethylmethoxy chromanol is present in an amount between 0.01 and 1%.

13. The antioxidant composition of claim 1 , wherein the silicone oil is cyclopentasiloxane or a combination of cyclopentasiloxane and polysilicone-11.

14. The antioxidant composition of claim 1 , wherein the one or more polyphenol antioxidants is selected from the group consisting of flavonoids; flavonols; flavones; catechins; flavanones; anthocyanidins; isoflavonoids; extracts from green tree extracts, milk thistle, soybeans, wine grapes and their seeds, acai berry, coffee berry, feverfew, pomegranate, tropical ferns, and turmeric; and any combinations thereof.

15. The antioxidant composition of claim 14 , wherein the polyphenol antioxidant is epigallocatechin gallate (EGCG).

16. The antioxidant composition of claim 15 , wherein the epigallocatechin gallate (EGCG) is present in an amount between 0.01 and 0.5%.

17. The antioxidant composition of claim 1 , wherein Vitamin C is present in an amount between 1 and 30%, Vitamin E is present in an amount between 0.1 and 5%, and the one or more polyphenol antioxidants is epigallocatechin gallate (EGCG) present in an amount between 0.01 and 0.5%.

18. The antioxidant composition of claim 17 , wherein the composition further comprises a low molecular weight chromane or chromene derivative with antioxidant properties, wherein the low molecular weight chromane or chromene derivative with antioxidant properties is dimethylmethoxy chromanol present in an amount between 0.01 and 0.5%.

19. The antioxidant composition of claim 18 , wherein the composition further comprises creatine present in an amount between 0.1 and 5%.

20. The antioxidant composition of claim 17 , wherein the composition further comprises creatine present in an amount between 0.1 and 5%.

21. The antioxidant composition of claim 1 , wherein the composition further comprises one or more carriers or excipients suitable for topical administration or subcutaneous administration.

22. The antioxidant composition of claim 1 , wherein the Vitamin C is micronized Vitamin C.

23. The antioxidant composition of claim 1 , wherein the composition is substantially free of water.

24. The composition of claim 1 , wherein the composition further comprises one or more additional active ingredients.

25. A pharmaceutical composition comprising the composition of claim 1 and one or more pharmaceutically acceptable carriers.

26. A cosmetic composition comprising the composition of claim 1 and one or more cosmetically acceptable carriers.

27. A kit comprising, in one or more containers, the pharmaceutical composition of claim 25 and instructions for use.

28. A kit comprising, in one or more containers, the cosmetic composition of claim 26 and instructions for use.

29. A method of treating, alleviating, or ameliorating a symptom, condition, disorder, or disease associated with free radicals, the method comprising administering an effective amount of the composition of claim 1 to a patient in need thereof.

30. The method of claim 29 , wherein the symptom, condition, disorder, or disease associated with free radicals is selected from the group consisting of sun induced skin damages, skin aging, skin inflammatory diseases or disorders, skin degenerative diseases or disorders, and cancer.

31. The method of claim 29 , wherein treating, alleviating, or ameliorating the symptom neutralizes free radicals.

32. The method of claim 29 , wherein the method comprises the repeated topical administration of the composition to the patient.

33. The method of claim 32 , wherein the composition is administered to the patient at least once or twice a day for at least 30 days.

34. The method of claim 29 , wherein the method comprises the repeated subcutaneous administration of the composition to the patient.

35. The method of claim 34 , wherein the composition is administered to the patient at least once or twice a day for at least 30 days.

36. A method for modifying free radical damage to skin by administering an effective amount of the composition of claim 1 to the skin of a patient.

37. The method of claim 36 , wherein the effective amount is sufficient to treat, prevent, or treat and prevent free radical damage to the skin.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ADDRESS OF ASSIGNEE PREVIOUSLY RECORDED ON REEL 041940 FRAME 0065. ASSIGNOR(S) HEREBY CONFIRMS THE CONVEYANCE FROM NEOCUTIS SA TO ANTEIS SA. Recorded Apr 28, 2017
From: NEOCUTIS SA
To: ANTEIS SA
Reel/Frame 042359/0065 →
MERGER AND CHANGE OF NAME Recorded Apr 3, 2017
From: NEOCUTIS SA; ANTEIS SA
To: ANTEIS SA
Reel/Frame 041827/0454 →
MERGER Recorded Mar 9, 2017
From: NEOCUTIS SA
To: ANTEIS SA
Reel/Frame 041940/0065 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2014
From: DREHER, FRANK
To: NEOCUTIS S.A.
Reel/Frame 032888/0311 →
Continuity (4)
Provisional Application 61875294 · Sep 9, 2013
Provisional Application 61830423 · Jun 3, 2013
Provisional Application 61814791 · Apr 22, 2013
Related Publication 20140315995A1 · Oct 23, 2014